BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23886940)

  • 1. Α-arrestin 1 (ARRDC1) and β-arrestins cooperate to mediate Notch degradation in mammals.
    Puca L; Chastagner P; Meas-Yedid V; Israël A; Brou C
    J Cell Sci; 2013 Oct; 126(Pt 19):4457-68. PubMed ID: 23886940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-arrestins - new players in Notch and GPCR signaling pathways in mammals.
    Puca L; Brou C
    J Cell Sci; 2014 Apr; 127(Pt 7):1359-67. PubMed ID: 24687185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nedd4-1 and beta-arrestin-1 are key regulators of Na+/H+ exchanger 1 ubiquitylation, endocytosis, and function.
    Simonin A; Fuster D
    J Biol Chem; 2010 Dec; 285(49):38293-303. PubMed ID: 20855896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Notch signalling by non-visual beta-arrestin.
    Mukherjee A; Veraksa A; Bauer A; Rosse C; Camonis J; Artavanis-Tsakonas S
    Nat Cell Biol; 2005 Dec; 7(12):1191-201. PubMed ID: 16284625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
    Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIP4/Itch regulates Notch receptor degradation in the absence of ligand.
    Chastagner P; Israël A; Brou C
    PLoS One; 2008 Jul; 3(7):e2735. PubMed ID: 18628966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinases and their emerging roles in β-arrestin-mediated signaling.
    Shenoy SK
    Methods Enzymol; 2014; 535():351-70. PubMed ID: 24377933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.
    Xiao J; Shi Q; Li W; Mu X; Peng J; Li M; Chen M; Huang H; Wang C; Gao K; Fan J
    Am J Cancer Res; 2018; 8(1):132-143. PubMed ID: 29416926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
    Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation attenuates human β-arrestin 2 inhibition of IL-1R/TRAF6 signaling.
    Xiao N; Li H; Mei W; Cheng J
    J Biol Chem; 2015 Jan; 290(4):1927-35. PubMed ID: 25425640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors.
    Urs NM; Jones KT; Salo PD; Severin JE; Trejo J; Radhakrishna H
    J Cell Sci; 2005 Nov; 118(Pt 22):5291-304. PubMed ID: 16263766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between the ESCRT-III complex and Deltex defines a ligand-independent Notch signal.
    Hori K; Sen A; Kirchhausen T; Artavanis-Tsakonas S
    J Cell Biol; 2011 Dec; 195(6):1005-15. PubMed ID: 22162134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma membrane-derived extracellular microvesicles mediate non-canonical intercellular NOTCH signaling.
    Wang Q; Lu Q
    Nat Commun; 2017 Sep; 8(1):709. PubMed ID: 28955033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis.
    Smith J; Yu R; Hinkle PM
    Mol Endocrinol; 2001 Sep; 15(9):1539-48. PubMed ID: 11518803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin signal complex plays a critical role in adipose differentiation.
    Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrestins and protein ubiquitination.
    Kommaddi RP; Shenoy SK
    Prog Mol Biol Transl Sci; 2013; 118():175-204. PubMed ID: 23764054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.